NYKODE THERAPEUTICS ASA
Home - Nykode
The Nykode Therapeutics platform is built around the Vaccibody molecule: A vaccine platform for the future of medicine.
Organization
- CEO
- MT
- Chairman of the board
- SS
Susanne Stuffers1981
- Years since formation
- 18 years
- since Jan 13, 2007
- Type
- Public limited company
- VAT registered
- Yes
- Number of employees
- 59
Ownership
- Number of shares and share classes
- 326,546,444
- 1 share class
- Total number of shareholders
- 8553
- 1,141 companies, 7,412 persons
Financials
- Total operating income 2024
- 9,158,000
- NOK
- Annual total result 2024
- -38,479,000
- NOK
- Total equity 2024
- 140,142,000
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MT | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
CÅ | Board Member | - |
TL 1969 | Board Member | - |
SS 1981 | Chairman | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JH | - | 4.95 % directly 0.07 % indirectly 4.88 % |
| - | 3.95 % indirectly | |
HA 1971 | - | 3.75 % indirectly |
OM | - | 2 % indirectly |
UA | - | 1.47 % indirectly |
EA | - | 1.47 % indirectly |
| - | 1.37 % indirectly | |
CR | - | 1.2 % indirectly |
DR 1968 | - | 1.18 % directly 0.05 % indirectly 1.13 % |
EA 1964 | - | 1.04 % indirectly |
Last update: May 8, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010714785 | 30,180,750 | 9.24 % | |
| NO0010714785 | 26,000,000 | 7.96 % | |
| NO0010714785 | 17,705,175 | 5.42 % | |
| NO0010714785 | 15,059,261 | 4.61 % | |
| NO0010714785 | 12,996,755 | 3.98 % | |
| NO0010714785 | 12,560,250 | 3.85 % | |
| NO0010714785 | 10,561,631 | 3.23 % | |
| NO0010714785 | 10,315,311 | 3.16 % | |
| NO0010714785 | 6,519,525 | 2 % | |
| NO0010714785 | 4,500,000 | 1.38 % | |
| NO0010714785 | 4,470,100 | 1.37 % | |
| NO0010714785 | 3,748,267 | 1.15 % | |
| NO0010714785 | 3,498,445 | 1.07 % | |
| NO0010714785 | 2,828,203 | 0.87 % | |
| NO0010714785 | 2,753,846 | 0.84 % | |
| NO0010714785 | 2,682,839 | 0.82 % | |
| NO0010714785 | 2,395,500 | 0.73 % | |
| NO0010714785 | 2,255,034 | 0.69 % | |
| NO0010714785 | 2,155,295 | 0.66 % | |
| NO0010714785 | 2,004,477 | 0.61 % | |
| NO0010714785 | 2,000,000 | 0.61 % | |
| NO0010714785 | 1,900,000 | 0.58 % | |
| NO0010714785 | 1,882,900 | 0.58 % | |
| NO0010714785 | 1,875,000 | 0.57 % | |
| NO0010714785 | 1,775,000 | 0.54 % | |
| NO0010714785 | 1,766,666 | 0.54 % | |
BB 1951 | NO0010714785 | 1,609,741 | 0.49 % |
| NO0010714785 | 1,350,000 | 0.41 % | |
TC | NO0010714785 | 1,335,000 | 0.41 % |
| NO0010714785 | 1,250,000 | 0.38 % | |
| NO0010714785 | 1,232,944 | 0.38 % | |
| NO0010714785 | 1,210,000 | 0.37 % | |
| NO0010714785 | 1,193,531 | 0.37 % | |
| NO0010714785 | 1,144,500 | 0.35 % | |
| NO0010714785 | 1,130,000 | 0.35 % | |
TE 1960 | NO0010714785 | 1,120,831 | 0.34 % |
| NO0010714785 | 1,100,000 | 0.34 % | |
| NO0010714785 | 1,100,000 | 0.34 % | |
| NO0010714785 | 1,100,000 | 0.34 % | |
JF | NO0010714785 | 1,100,000 | 0.34 % |
| NO0010714785 | 1,021,741 | 0.31 % | |
| NO0010714785 | 1,000,000 | 0.31 % | |
| NO0010714785 | 1,000,000 | 0.31 % | |
RF | NO0010714785 | 1,000,000 | 0.31 % |
| NO0010714785 | 1,000,000 | 0.31 % | |
| NO0010714785 | 948,979 | 0.29 % | |
| NO0010714785 | 915,000 | 0.28 % | |
| NO0010714785 | 900,059 | 0.28 % | |
| NO0010714785 | 890,797 | 0.27 % | |
| NO0010714785 | 885,000 | 0.27 % | |
| NO0010714785 | 869,773 | 0.27 % | |
| NO0010714785 | 851,739 | 0.26 % | |
| NO0010714785 | 840,000 | 0.26 % | |
| NO0010714785 | 822,600 | 0.25 % | |
| NO0010714785 | 800,000 | 0.24 % | |
| NO0010714785 | 800,000 | 0.24 % | |
| NO0010714785 | 771,221 | 0.24 % | |
| NO0010714785 | 770,000 | 0.24 % | |
| NO0010714785 | 762,500 | 0.23 % | |
| NO0010714785 | 750,000 | 0.23 % | |
| NO0010714785 | 747,265 | 0.23 % | |
| NO0010714785 | 700,000 | 0.21 % | |
KV 1976 | NO0010714785 | 693,707 | 0.21 % |
| NO0010714785 | 676,656 | 0.21 % | |
AG | NO0010714785 | 673,821 | 0.21 % |
| NO0010714785 | 650,000 | 0.2 % | |
| NO0010714785 | 650,000 | 0.2 % | |
MJ 1968 | NO0010714785 | 610,000 | 0.19 % |
| NO0010714785 | 607,000 | 0.19 % | |
| NO0010714785 | 600,000 | 0.18 % | |
| NO0010714785 | 600,000 | 0.18 % | |
JH | NO0010714785 | 593,000 | 0.18 % |
IA 1946 | NO0010714785 | 551,434 | 0.17 % |
| NO0010714785 | 550,000 | 0.17 % | |
| NO0010714785 | 550,000 | 0.17 % | |
| NO0010714785 | 503,013 | 0.15 % | |
| NO0010714785 | 500,000 | 0.15 % | |
| NO0010714785 | 500,000 | 0.15 % | |
| NO0010714785 | 500,000 | 0.15 % | |
| NO0010714785 | 500,000 | 0.15 % | |
| NO0010714785 | 500,000 | 0.15 % | |
| NO0010714785 | 495,000 | 0.15 % | |
| NO0010714785 | 465,228 | 0.14 % | |
| NO0010714785 | 459,918 | 0.14 % | |
| NO0010714785 | 454,020 | 0.14 % | |
| NO0010714785 | 436,488 | 0.13 % | |
| NO0010714785 | 430,000 | 0.13 % | |
JA | NO0010714785 | 421,695 | 0.13 % |
| NO0010714785 | 400,000 | 0.12 % | |
| NO0010714785 | 400,000 | 0.12 % | |
| NO0010714785 | 400,000 | 0.12 % | |
| NO0010714785 | 400,000 | 0.12 % | |
| NO0010714785 | 386,240 | 0.12 % | |
| NO0010714785 | 382,961 | 0.12 % | |
| NO0010714785 | 380,000 | 0.12 % | |
| NO0010714785 | 370,000 | 0.11 % | |
BS | NO0010714785 | 368,991 | 0.11 % |
| NO0010714785 | 368,270 | 0.11 % | |
| NO0010714785 | 365,000 | 0.11 % | |
| NO0010714785 | 360,000 | 0.11 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 9,158,000 | 13,362,000 | 9,029,000 | 35,766,000 |
Annual Total Result | -38,479,000 | -33,392,000 | -41,680,000 | -8,597,000 |
Total assets | 156,082,000 | 210,353,000 | 223,706,000 | 265,755,000 |
Total liabilities | 15,940,000 | 35,521,000 | 64,880,000 | 70,888,000 |
Total equity | 140,142,000 | 174,832,000 | 158,826,000 | 194,866,000 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 9,158,000 | 13,362,000 | 9,029,000 | 35,766,000 |
Total operating costs | 54,906,000 | 69,842,000 | 61,177,000 | 45,682,000 |
Operating result | -45,748,000 | -56,480,000 | -52,148,000 | -9,916,000 |
Financial income/costs | 547,000 | 14,051,000 | 2,148,000 | -412,000 |
Profit before tax | -45,201,000 | -42,429,000 | -50,000,000 | -10,328,000 |
Total tax & extraordinary income/cost | -6,722,000 | -9,037,000 | -8,320,000 | -1,731,000 |
Annual Total Result | -38,479,000 | -33,392,000 | -41,680,000 | -8,597,000 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 40,494,000 | 45,910,000 | 12,636,000 | 10,527,000 |
Total current assets | 115,588,000 | 164,443,000 | 211,070,000 | 255,228,000 |
Total assets | 156,082,000 | 210,353,000 | 223,706,000 | 265,755,000 |
Short term debt | 8,083,000 | 19,855,000 | 39,406,000 | 30,754,000 |
Long term debt | 7,857,000 | 15,666,000 | 25,474,000 | 40,134,000 |
Total liabilities | 15,940,000 | 35,521,000 | 64,880,000 | 70,888,000 |
Contributed capital | 144,922,000 | 141,633,000 | 83,656,000 | 89,708,000 |
Retained earnings | -4,780,000 | 33,199,000 | 75,170,000 | 105,158,000 |
Total equity | 140,142,000 | 174,832,000 | 158,826,000 | 194,866,000 |
Total equity and liabilities | 156,082,000 | 210,353,000 | 223,706,000 | 265,754,000 |
Classification
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises